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a b s t r a c t
This studyexploreddifferencesbetweenSpitzer’sproposedmodelofposttraumatic stressdisorder (PTSD)
and the current DSM-IV diagnostic classification scheme in 353 Veterans. Themajority of Veterans (89%)
diagnosed with PTSD as specified in the DSM-IV also met Spitzer’s proposed criteria. Veterans who met
both DSM-IV and Spitzer’s proposed criteria had significantly higher Clinician Administered PTSD Scale
severity scores than Veterans only meeting DSM-IV criteria. Logistic regression indicated that being
AfricanAmerican andhavingno comorbiddiagnosis ofmajor depressivedisorder orhistory of a substance
use disorder were found to predict those Veterans who met current, but not proposed criteria. These
findings have important implications regarding proposed changes to the diagnostic classification criteria
for PTSD in the forthcoming DSM-V.
© 2011 Elsevier Ltd. All rights reserved.
1. Introduction
Since the admission of posttraumatic stress disorder (PTSD) to
the diagnostic nomenclature in the third edition of the Diagnos-
tic and Statistical Manual of Mental Disorders (DSM-III; American
Psychiatric Association, 1980), researchers have investigated vari-
ous diagnostic conceptualizations for PTSD (Breslau & Davis, 1987;
Burstow, 2005; McNally, 2004). Ongoing evaluation, and possibly
updating, of PTSD criteria is essential in order to reflect current
research findings on the etiology, presentation, and diagnosis of
PTSD. An accurate understanding and conceptualization of post-
traumatic symptoms are fundamental prerequisites to developing
effective treatments to decrease, and potentially to protect against
psychological distress associated with the effects of trauma.
In anticipation of the upcoming DSM-V, numerous researchers
have proposed revised criteria for PTSD (Brewin, Lanius, Novac,
Schnyder, & Galea, 2009; DSM-V Task Force, 2010; Spitzer, First,
& Wakefield, 2007) that more clearly reflect the latest research
results. Most recently the DSM-V Task Force (2010) has proposed
PTSD diagnostic criteria that includes a broader range of symptoms
thatmay bemore inclusive, while other researchers have proposed
revised criteria for PTSD that would tighten the PTSD diagnostic
classification (Brewin et al., 2009; Spitzer et al., 2007). These later
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proposals are in response to many researchers who argue that the
newcriteria shouldbemore specific toaunique traumarelated syn-
drome (Bodkin, Pope, Detke, & Hudson, 2007; Brewin et al., 2009;
McNally, 2004).
Many have questioned the specificity of PTSD (Bodkin et al.,
2007;Brewinet al., 2009;Green, Lindy,&Grace, 1985; Lindy,Green,
& Grace, 1987) due to the significant symptom overlap with other
disorders, especially Major Depressive Disorder (MDD) and Gen-
eralized Anxiety Disorder (GAD). For example, anhedonia, lack of
concentration, and problems with sleep as well as irritability are
all features of PTSD that are also characteristic of depression (APA,
2000; Fava et al., 2010). In addition, impaired concentration, hyper-
arousal and sleep difficulty are also characteristic of GAD (APA,
2000). If researchers are correct in their assumption that the symp-
tom overlap decreases the diagnostic specificity of PTSD, then by
extensionPTSDhas likelybeen lacking specificity since its existence
in the psychiatric nomenclature. This hypothesis is not surpris-
ing given the significant comorbidity of PTSD, MDD, and GAD. The
National Comorbidity Survey (Kessler, Sonnega, Hughes, & Nelson,
1995) estimated nearly 50% of men and women who had PTSD
also had MDD. Other studies have found estimates of comorbid
PTSD and MDD as high as 77% and estimates of PTSD and GAD as
high as 38% (Brown, Campbell, Lehman, Grisham, &Mancill, 2001).
Generally, PTSDdemonstrates oneof thehighest rates of comorbid-
ity among psychiatric disorders (Kessler, Chiu, Demler, & Walters,
2005).
Regardless of symptom overlap and high comorbidity, many
researchers argue that PTSD is unique and distinguishable from
MDD (Blanchard, Buckley, Hickling, & Taylor, 1998) and GAD
0887-6185/$ – see front matter © 2011 Elsevier Ltd. All rights reserved.
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(Keane, Taylor, & Penk, 1997). Researchers who have examined the
impact of these overlapping symptoms on comorbidity in individ-
uals with PTSD have found no difference in comorbid MDD rates
(Elhai, Grubaugh, Kashdan, & Frueh, 2008; Franklin & Zimmerman,
2001). In addition, Barlow, DiNardo, Vermilyea, Vermilyea, and
Blanchard (1986) have argued that symptom overlap among dis-
orders is merely evidence that psychopathology arises from a
constitutional predisposition involving many factors and mani-
fests accordingly due to individual and environmental influences.
Others, however, continue to debate the issue and insist that the
symptom overlap of PTSD and other psychiatric disorders is a fun-
damental flaw of the diagnosis and confounds the specificity of the
syndrome (Bodkin et al., 2007; Breslau & Davis, 1987).
Spitzer et al. (2007) agreedwithmany of the assertions suggest-
ing that the current criteria for PTSD are flawed and they proposed
the following revisions to the diagnostic classification. Although
they suggested changing the stressor criterion and the specifiers
of the diagnosis, the most significant modifications were recom-
mended to address the issue of poor specificity. Specifically, they
proposed eliminating the symptoms of PTSD that overlap with
other disorders, including sleep problems, anhedonia, difficulty
concentrating, and irritability, within the avoidance and hyper-
arousal criteria. Additional suggested changes appeared to be less
linked to current criticism and included (1) deleting impaired recall
of an important element of the trauma (C3 criterion). The authors
did not fully discuss their rationale for this change but they may
have been responding to the numerous studies that have found
poor correlations between the C3 criterion and other PTSD symp-
toms (Buckley, Blanchard, & Hickling, 1998; King, Leskin, King, &
Weathers, 1998; Simms,Watson, &Doebbeling, 2002); (2) combin-
ing the remaining C and D criteria into a single list rather than two
separate criterion categories. The new criterion C would include
the following symptoms: (1) efforts to avoid thoughts, feelings, or
conversations associatedwith the trauma, (2) efforts to avoid activ-
ities, places, or people that arouse recollections of the trauma, (3)
feelings of detachment or estrangement from others, (4) restricted
range of affect, (5) sense of a foreshortened future, (6) hypervig-
ilance, and (7) exaggerated startle response; and (3) requiring at
least four of the symptoms in this combined group along with the
other criteria for the diagnosis to be met.
A reviewof the literature revealed three studies todate thathave
examined Spitzer’s proposed criteria (Elhai et al., 2008; Ford, Elhai,
Ruggiero, & Frueh, 2009; Grubaugh, Long, Elhai, Frueh, &Magruder,
2010). Thus far, when Spitzer’s proposed criteriawere compared to
the currentDSM-IVcriteria, researchers found little ornodifference
in lifetime PTSD prevalence among adult community (Elhai et al.,
2008) and primary care veteran samples (Grubaugh et al., 2010).
In contrast, lower rates of lifetime PTSD prevalence were identi-
fied when Spitzer’s criterion set was employed in a community
sample of adolescents (Ford et al., 2009). With regards to psychi-
atric comorbidity, all three studies revealed no difference when
Spitzer’s criteria were compared to the current DSM-IV criterion
set. However,when Ford et al. (2009) utilized an alternative criteria
threshold (three versus four hyperarousal/avoidance symptoms)
for Spitzer’s model, they found lower rates of comorbid depression
in their sample of adolescents. Additionally, lifetime PTSD preva-
lence rates among the adolescent sample also became comparable
to current lifetime rates once the criterion threshold was manip-
ulated. Furthermore, all three studies found Spitzer’s two factor
model of PTSD to be structurally adequate and superior to the cur-
rent three factormodel. Therefore, the findings examining Spitzer’s
revised criterion set have been mixed.
The current study extended these previous findings by examin-
ing the impact of utilizing Spitzer’s proposed criteria on a Veteran
population seeking treatment for PTSD. This study identified the
proportion of Veteranswhomet PTSD diagnostic criteria according
to both the DSM-IV and Spitzer’s proposed criteria as well as those
who no longer met diagnostic criteria when Spitzer’s criteria were
employed. Additionally, this study examined potential predictors
for maintaining a diagnosis of PTSD using Spitzer’s criteria. Comor-
bidity of PTSD with MDD, GAD, and substance use disorders was
also explored as a potential predictor due to prior research demon-
strating high comorbidity of these disorders (Brown et al., 2001;
Kessler et al., 2005, 1995). Additionally, individuals with PTSD and
other comorbid disorders such as depression and substance abuse
have been found to evidence more severe PTSD symptomatology
(Back, Sonne, Killeen, Dansky, & Brady, 2003; Momartin, Silove,
Manicavasagar, & Steel, 2004), and typically have poorer treat-
mentoutcomes (Cloitre&Koenen, 2001). Therefore, PTSDsymptom
severity was examined as a potential predictor of group member-
ship. Although researchers have found no consistent difference in
demographic variables among individuals with PTSD with regards
to PTSD symptom severity (Frueh, Brady, & de Arellano, 1998;
Norris, 1992; Pole, Gone, & Kulkarni, 2008; Roemer, Litz, Orsillo,
Ehlich, & Friedman, 1998; Ullman, Filipas, Townsend, & Starzynski,
2007), thesevariableswerealso investigatedaspotential predictors
of group membership.
2. Method
2.1. Procedure and participants
Before initiation of the study, approval from appropriate Insti-
tutional Review Boards was obtained. Archival data of male and
female Veterans from a Midwestern VA Medical Center PTSD and
Anxiety Disorders Clinic (PTSD Clinic) was entered into a database
and included demographic characteristics and test scores for each
veteran. Datawas derived fromconsecutive admissions to the PTSD
Clinic from January 2006 to May 2008 (n=555). Veterans who did
not meet either current or proposed criteria (n=193) for PTSD, as
measured by the Clinician Administered PTSD Scale (CAPS), were
excluded, leaving 362 Veterans that were included in the analy-
ses for this study. As shown in Table 1, 93.1% were outpatients,
88.7% were male, and 79.0% wereWhite. Additionally, 48.6% of the
Veterans were from the Vietnam era, 67.1% had combat related
traumas, 60.8%hadadiagnosis ofmajor depressivedisorder (MDD),
40.1% had a history of a substance use disorder (SUD), and 12.2%
had no other Axis I diagnosis (NODX). Further information on the
population and groups examined can be found in Table 1.
2.2. Measures
CAPS (Blake et al., 1990). The CAPS was used to determine diag-
nostic criteria for both current DSM-IV PTSD criteria and Spitzer’s
proposed criteria for DSM-V as well as to assess severity of PTSD
symptoms. The CAPS is a structured clinical interview that is con-
sidered the “gold standard” in assessment of PTSD (Keane, Brief,
Pratt, & Miller, 2007). The CAPS has the unique ability to measure
PTSD symptomatology both dichotomously and continuously. Each
symptom is rated on both frequency and intensity of occurrence.
Symptom criteria are scored on a scale of 0–4, with 0 represent-
ing absence of the symptom and 4 representing the greatest level
of severity. Several researchers have examined the different scor-
ing rules for the presence or absence of symptoms using the CAPS
to diagnose PTSD (Blanchard et al., 1995; Fleming & Difede, 1999;
Weathers, Ruscio, & Keane, 1999) and have suggestedmore lenient
scoring rules for screening, whilemore stringent scoring rules have
been suggested for confirming the diagnosis of PTSD. The current
study employed the original scoring rule proposed by Blake et al.
(1990)which specifies that a frequencyof oneormoreandan inten-
sity of two or more on a symptom constitutes a positive result for
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Table 1
Demographic characteristics.
Characteristic Overall (n=362) Met both (n=314) Met current only (n=39) Met proposed only (n=9)
Outpatient 93.1% 92.7% 94.9% 100%
Male 88.7% 88.2% 89.7% 100%
African American 14.9% 13.4% 28.2% 11.1%
White 79.0% 80.3% 66.7% 88.9%
Other race 5.8% 6.7% – –
Pre-Vietnam era 1.4% 1.0% 5.1% –
Vietnam era 48.6% 48.7% 43.6% 66.7%
Persian Gulf era 12.7% 12.7% 12.8% 11.1%
OEF/OIF era 25.7% 25.8% 30.8% –
Other era 0.08% 0.06% – 11.1%
Combat trauma 67.1% 67.2% 64.1% 77.8%
MDD 60.8% 64.0% 43.6% 22.2%
SUD 42.4% 42.4% 23.1% 33.3%
OTHER 40.6% 41.5% 38.5% 33.3%
NODX 10.2% 10.2% 23.1% 33.3%
Note. OEF/OIF: Operation Enduring Freedom/Operation Iraqi Freedom; MDD: major depressive disorder; SUD: history of a substance use disorder; OTHER: any other Axis I
diagnosis, except MDD or SUD; NODX: no diagnosis on Axis I.
that symptom. Although Blake’s scoring rule is more lenient than
others, it was used for two reasons. First, this scoring rule ensures
that all Veterans who are experiencing distress and meet criteria
can be treated. Second, this scoring rule was used in order to avoid
false negatives and increase true positives.
The CAPS can be administered using either a one week or one
month time frame (Blake et al., 1990). Data available for this study
was based upon the one week version. This time frame was uti-
lized for the clinical purpose of tracking pre- and post-treatment
symptom status related to the course of therapy. However, Veter-
ans were queried on the duration of their PTSD symptoms at the
initial assessment to establish PTSD diagnosis. Symptoms lasting
less than one month were not diagnosed as PTSD.
Weathers, Keane, and Davidson (2001) reviewed 10 years of
research establishing the psychometric properties of the CAPS.
Interrater reliability was at or above the .90 level for continuous
CAPS scores, while test–retest reliability was similarly high at .93
or above. Internal consistency was also high with alphas ranging
from .80 to .90 across symptoms clusters and with all 17 symp-
toms. Convergent validitywas in the .70–.90 rangewhen compared
to self-report measures of PTSD. Diagnostic utility evidenced sen-
sitivities and specificities above .80 and kappas above .70.
SCID-IV (First, Spitzer, Williams, & Gibbon, 2000). The SCID-IV
was used in this study to assess comorbid psychiatric conditions on
Axis I. The SCID-IV is a semi-structured interview that corresponds
to the DSM-IV diagnostic criteria. The SCID-IV has demonstrated
high interrater reliability and adequate reliability in the assess-
ment of awide rangeof disorders (Hoffart, Thornes, &Hedley, 1995;
Schlenger et al., 1992; Ventura, Liberman, Green, Shaner, & Mintz,
1998). For this study, the authors only reviewed veteran’s results
on the Depression, Anxiety, and Substance Use modules as well as
the screening module for Psychotic Disorders.
3. Results
3.1. Diagnostic frequencies
Frequency counts were conducted to determine how many
participants met both current and proposed criteria (BOTH), only
current criteria (CRT), or only proposed criteria for PTSD (PROP). A
total of 314 Veterans were in the BOTH group, 39 Veterans were in
the CRT group, and 9 Veterans were in the PROP group. The major-
ity (89%) of Veteranswhomet the current criteria for PTSD alsomet
Spitzer’s proposed criteria. Interestingly, 2% (n=9) of the Veterans
examined who did not meet the current criteria for PTSD in DSM-
IV, met the proposed criteria for PTSD. This group was excluded
from further analyses due to the small number of Veterans in the
group.
3.2. Demographic comparisons between groups
Next, demographic differences between the BOTH and CRT
groups were compared. Omitted demographic data were excluded
from the respective analyses. There was a significant difference in
educational level between the BOTH (M=12.94, SD=1.97) and CRT
group (M=13.89, SD=2.20), t (327) =−2.70, p< .05; however, the
effect size (d=0.009) indicated that although education was statis-
ticallydifferent, themagnitudeof thedifferencebetweeneducation
levels was not practically relevant. There was no difference found
between the BOTH and CRT groups with regards to age, gender, or
service era.
Examination of race indicated that African American Veterans
weremore likely to be in the CRT group than in the BOTH group, 2
(n=331, 1) =5.83, p= .02, ϕ =0.13. An additional analysis was com-
pleted to determine if there was a difference between race and
PTSD symptom severity in the overall sample. The BOTH group
was comprised of 86% White Veterans versus 14% African Amer-
ican Veterans, while the CRT group was comprised of 70% White
Veterans versus 30% African American Veterans. The two groups
did not meet the assumption of equal variance; therefore, t-test
comparisons were based on the assumption that variances were
not equal between the two groups. Individual sample t-test indi-
cated that there was no difference between African Americans and
Whites in PTSD symptom severity in the overall sample. Veterans
identified as Hispanic/Latino, other, or anothermulticultural group
were excluded in the final analysis of race due to small size (n=9).
3.3. PTSD severity comparisons between groups
The individual symptomclusters (B, C, andDcriteria) andoverall
total CAPS scores of the BOTH and CRT groups were then exam-
ined to compare PTSD symptom severity. Individual sample t-tests
were employed to compare symptom severity between the BOTH
and CRT groups across the symptom clusters and overall totals. The
BOTH group’s total reexperiencing (criteria B), avoidance (criteria
C), and hyperarousal (criteria D) symptom severity cluster totals
were all significantly higher than the CRT group (see Table 2). Addi-
tionally, the BOTH group’s overall total symptom severity score on
the CAPS was significantly higher than the CRT group.
CAPS scores examining only Spitzer’s criteria were also com-
pared. Individual sample t-tests were employed to compare the
BOTH and CRT groups across the symptom clusters (B, C, and D cri-
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Table 2
CAPS scores comparison between Veterans who met both DSM-IV-TR and Spitzer’s proposed criteria for PTSD versus Veterans who only met current DSM-IV-TR criteria.
Meets both (n=314) M(SD) Meets current only (n=39) M(SD) t p Cohen’s d
DSM-IV-TR
B total 19.0(6.9) 14.1(5.4) 4.23 <.001 0.45
C total 29.4(8.1) 19.8(5.3) 10.02 <.001 2.53
D total 24.0(5.7) 18.0(5.5) 6.26 <.001 0.67
Overall total 72.5(15.9) 51.9(10.1) 11.11 <.001 2.77
Spitzer proposed
Overall total 50.8(12.1) 31.5(8.0) 13.3 <.001 3.38
Note. Levene’s test for equality of variances showed that the two groups had significantly different variances on C total and overall total (p< .01). Therefore, reported t-tests
for C total and overall total scores are based upon corrections that do not assume equal variances.
teria) and overall total with only Spitzer’s proposed criteria. The
BOTH group had significantly higher total overall CAPS scores on
the 12 symptoms when compared to the CRT group (see Table 2).
3.4. Psychiatric comorbidity comparisons between groups
Next, differences in psychiatric comorbidity between the BOTH
and CRT group were explored. Omitted diagnostic data were
excluded from the respective analyses. The data indicated that
Veterans in the BOTH group were more likely to have a diagno-
sis of MDD than Veterans in the CRT group, 2(n=353, 1) =6.13,
df=1, p= .01, ϕ =0.13. Sixty-four percent of Veterans in the BOTH
group also met criteria for depression versus only 44% in the CRT
group. Next, Veterans in the BOTH group were more likely to have
SUD than Veterans in the CRT group, 2 (n=353, 1) =5.36, p= .02,
ϕ =0.12. Forty-two percent of Veterans in the BOTH group reported
SUD versus only 23% in the CRT group. Additionally, Veterans in
the CRT groupweremore likely to have NODX than Veterans in the
BOTH group, 2 (n=353, 1) =5.61, p= .02, ϕ =0.13. Twenty-three
percent of Veterans in the CRT group had no other Axis I diagnosis
versus 10% of Veterans in the BOTH group. Finally, other comor-
bid diagnoses were examined, with particular interest in comorbid
anxiety disorders. Analyses of all other Axis I disorders examined
indicated no differences between the BOTH and CRT groups.
3.5. Predictions of group membership
Variables that significantly differentiated the CRT from BOTH
groups in bivariate analyses were entered into amultivariate logis-
tic regression that included CRT versus BOTH as the outcome
variable. The odds ratio (OR) and 95% confidence intervals (CIs) for
each variable in the analysis are presented in Table 3. In the final
model, African Americans were over 30% more likely to be in the
CRT group than Whites. Veterans with a diagnosis of MDD were
almost 45% more likely to be in the BOTH group than those with-
out MDD. Likewise, Veterans with SUD were 40% more likely to be
in the BOTH group than Veterans without SUD. Education was not
significantly related to BOTH versus CRT group membership.
4. Discussion
The results of this study showed that the majority of Veter-
ans (89%) who met criteria for PTSD in DSM-IV also met Spitzer’s
proposed criteria. In the overall sample there was no difference
between African Americans and Whites in PTSD symptom sever-
ity. However, African America race, less psychiatric comorbidity of
MDD and SUD, and less severe PTSD symptomatology predicted
Veterans who met DSM-IV PTSD criteria, but not Spitzer’s pro-
posed PTSD criteria. Additionally, although a significant difference
was found for education in the CRT versus BOTH group in bivari-
ate comparisons, results suggested that this difference is probably
accounted for by other variables, including race and psychiatric
comorbidity.
In contrast to previous studies examining Spitzer’s proposed
PTSD criteria that found no difference in psychiatric comorbidity
when comparing individuals who met both current and proposed
PTSD criteria and those who only met current (Elhai et al., 2008;
Ford et al., 2009; Grubaugh et al., 2010), the current study found
greater comorbity of substance use disorders and MDD among the
group that met both PTSD criteria. Additionally, the group that
met both criteria evidenced greater PTSD symptom severity. These
findings are consistent with research that has shown a relation-
ship between PTSD symptom severity and comorbid depression
and substance abuse (Back et al., 2003; Momartin et al., 2004).
Thus, Spitzer’s revised criterion set may have identified those indi-
viduals who manifested greater psychopathology in response to
psychological trauma.
In addition to these findings, White Veterans in this study
appeared to endorse fewer of the PTSD symptoms that over-
lap with other disorders—the symptoms Spitzer et al. proposed
deleting—and had a greater likelihood of meeting the proposed
criteria. These results indicate that the manifestation of trauma-
related symptomatology may be different in White Veterans as
compared to African American Veterans. Thus, if Spitzer’s crite-
ria are endorsed, some groups of Veterans, including those who
are African American, might be less likely to be diagnosed with
PTSD. Instead the distress reactions of these Veteransmay bemore
susceptible to classification as a mood disorder, such as major
depression. In this case, it is possible that Veterans who meet the
current, but not Spitzer’s proposed criteria would be more likely
to receive mood- rather than PTSD-focused interventions. This
suggests a clear need for research to better understand whether
mood-focused interventions are efficacious for treating veterans
with lower severity PTSD who do not meet criteria for Spitzer’s
proposed diagnostic revision for PTSD. These findings also suggest
a need to better understand factors that may underlie differences
in veterans’ post-traumatic psychological distress reactions across
ethnic groups.
Table 3
Multivariate regression predicting outcome, with BOTH group as referent category.
Variable Beta p OR 95% confidence interval
RACE 1.15 .009 0.32 0.13–0.75
EDUCATION 0.15 .088 1.16 0.98–1.38
MDD −0.82 .030 0.44 0.21–0.92
SUD −0.92 .039 0.40 0.17–0.96
Note. Race (African American=0; White =1); MDD: major depressive disorder; SUD: history of a substance use disorder.
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4.1. Limitations and recommendations for future research
There were several limitations to this study that should be
addressed in future research. First, the results of this studymay not
be generalizable to other populations due to this study’s focus on
Veterans, themajority of whichweremaleswho experienced com-
bat related traumas. Additionally, differences in trauma severity
and the impact of experiencing multiple traumas on group mem-
bership or symptom severity were not examined. Future research
should examine the proposed criteriawith a variety of traumas and
levels of symptom severity to determine any differences.
In addition, this study examined only one set of proposed PTSD
diagnostic criteria. Recent documents released by the DSM-V PTSD
Task Force (2010) suggest that they may be moving in the oppo-
site direction of Spitzer, withmore of a focus on broadening, rather
than tightening, the definition of PTSD. Specifically, the Task Force
proposes adding maladaptive cognitive changes as symptoms of
PTSD, while also adopting a four factor solution to the criterion
set, rather than the current three factor model. Many researchers
have identifiedflaws to the fundamental three factor solutionof the
current DSM-IV PTSD criteria and favor two or four factor solutions
(Amdur & Liberzon, 2001; Asmundson et al., 2000; Buckley et al.,
1998; King et al., 1998; Simms et al., 2002; Smith, Redd, DuHamel,
Vicksberg, & Ricketts, 1999; Taylor, Kuch, Koch, Crockett, & Passey,
1998). Future research examining the Task Force’s revised crite-
rion set with deletion of overlapping symptoms as proposed by
Spitzer is recommended in addition to evaluation of other alter-
native diagnostic classifications. Accordingly, these investigations
will also reveal potential treatment implications of adopting a new
diagnostic system for PTSD.
4.2. Conclusions
Spitzer et al. (2007) intended to improve the diagnostic crite-
ria for PTSD by proposing several changes to the criteria for PTSD
in the forthcoming DSM-V. The results of this study indicated that
Spitzer’s proposed changes may indeed make the diagnosis more
specific to unique PTSD symptomatology. Our findings suggest that
if Spitzer’s proposed changes to PTSD criteria in the DSM-V are
endorsed, thenewcriteriawill includemostof theVeteranswhoare
already diagnosed with PTSD (89% in this sample). However, more
than 10% of Veterans will no longer meet the diagnostic criteria
for PTSD. Based on this study, the new criteria may identify Veter-
ans with more severe psychopathology and those with less severe
symptomatology who no longer meet the diagnostic criteria will
no longer be labeled as having PTSD. Although these Veterans may
be experiencing less severe symptomatology, treatment may still
be important to address significant functional impairments. Fur-
ther research evaluating alternative diagnostic conceptualizations
and resultant treatment implications is essential to our ability to
develop and implement effective treatments for those who have
experienced psychological trauma.
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